Why the Bull Case for Texas Instruments Stock Is Robotics Semiconductor Demand

Texas Instruments' robotics semiconductor exposure explains Q1 2026's 19% stock surge and a bull case for further gains as demand accelerates.

Texas Instruments' robotics semiconductor exposure explains Q1 2026's 19% stock surge and a bull case for further gains as demand accelerates.

In early 2026, Stryker launched Mako RPS, a handheld version of its robotic knee surgery system, designed to reach ambulatory surgery centers (ASCs),...

RTX's military robotics programs are already in development—not future promises, but contracts with deployment timelines.

Pentagon planning to buy up to 1 million drones drives AeroVironment's record revenue growth and expands its multi-year backlog.

UiPath's path to profitability and accelerating growth positions it as a gatekeeper for enterprise automation at the moment when processes transition from rules-based to AI-driven.

John Deere's dealer network and data platform create structural advantages that make autonomous farming robots a natural next revenue stream for the company.

Zebra's exit from robotics hardware paradoxically strengthens its bull case: machine vision and tracking demand is accelerating, and Zebra now sells the software layer that powers automation.

ABB's bull case is electrification and automation dominance, not robotics—which it is selling to SoftBank.

Intuitive Surgical controls 80% of robotic surgery, making surgeon lock-in its most durable competitive advantage.

Nvidia's future growth depends partly on whether robotics AI deployment scales faster than skeptics expect.